Protara Therapeutics, Inc. Balance Sheet
TARA|3 years of annual SEC 10-K data (FY2014-FY2016)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 3 fiscal years. All figures from audited SEC 10-K filings.
Protara Therapeutics, Inc. had $44M in total assets and $82M in shareholders' equity as of FY2016.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.74 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2016 | FY2015 | FY2014 |
|---|---|---|---|
| Cash & Equivalents | $68.8M | $2.8M | $2.4M |
| Current Assets | $42.8M | $66.6M | $84.6M |
| PP&E (Net) | $372.0K | $224.0K | $83.0K |
| Total Assets | $43.5M | $67.5M | $84.8M |
| Current Liabilities | $5.1M | $4.1M | $2.3M |
| Shareholders' Equity | $82.5M | -$100.5M | -$86.7M |